CRMD
Price
$10.18
Change
+$0.10 (+0.99%)
Updated
Oct 17 closing price
Capitalization
794.64M
19 days until earnings call
Intraday Buy/Sell Signals
PXXLF
Price
$0.25
Change
-$0.45 (-64.29%)
Updated
Nov 25 closing price
Capitalization
24.34M
Intraday Buy/Sell Signals
Interact to see
Advertisement

CRMD vs PXXLF

Header iconCRMD vs PXXLF Comparison
Open Charts CRMD vs PXXLFBanner chart's image
CorMedix
Price$10.18
Change+$0.10 (+0.99%)
Volume$1.95M
Capitalization794.64M
Poxel SA
Price$0.25
Change-$0.45 (-64.29%)
Volume$750
Capitalization24.34M
CRMD vs PXXLF Comparison Chart in %
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. PXXLF commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Hold and PXXLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (CRMD: $10.18 vs. PXXLF: $0.25)
Brand notoriety: CRMD and PXXLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 58% vs. PXXLF: 100%
Market capitalization -- CRMD: $794.64M vs. PXXLF: $24.34M
CRMD [@Biotechnology] is valued at $794.64M. PXXLF’s [@Biotechnology] market capitalization is $24.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 1 FA rating(s) are green whilePXXLF’s FA Score has 1 green FA rating(s).

  • CRMD’s FA Score: 1 green, 4 red.
  • PXXLF’s FA Score: 1 green, 4 red.
According to our system of comparison, CRMD is a better buy in the long-term than PXXLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 4 TA indicator(s) are bullish.

  • CRMD’s TA Score: 4 bullish, 6 bearish.

Price Growth

CRMD (@Biotechnology) experienced а -5.13% price change this week, while PXXLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CRMD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($795M) has a higher market cap than PXXLF($24.3M). CRMD YTD gains are higher at: 25.679 vs. PXXLF (0.000).
CRMDPXXLFCRMD / PXXLF
Capitalization795M24.3M3,272%
EBITDA52.3MN/A-
Gain YTD25.6790.000-
P/E Ratio13.05N/A-
Revenue121MN/A-
Total Cash191MN/A-
Total Debt435KN/A-
FUNDAMENTALS RATINGS
CRMD vs PXXLF: Fundamental Ratings
CRMD
PXXLF
OUTLOOK RATING
1..100
7030
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
24100
PRICE GROWTH RATING
1..100
6078
P/E GROWTH RATING
1..100
991
SEASONALITY SCORE
1..100
9037

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRMD's Valuation (62) in the Medical Specialties industry is somewhat better than the same rating for PXXLF (96) in the null industry. This means that CRMD’s stock grew somewhat faster than PXXLF’s over the last 12 months.

CRMD's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as PXXLF (100) in the null industry. This means that CRMD’s stock grew similarly to PXXLF’s over the last 12 months.

CRMD's SMR Rating (24) in the Medical Specialties industry is significantly better than the same rating for PXXLF (100) in the null industry. This means that CRMD’s stock grew significantly faster than PXXLF’s over the last 12 months.

CRMD's Price Growth Rating (60) in the Medical Specialties industry is in the same range as PXXLF (78) in the null industry. This means that CRMD’s stock grew similarly to PXXLF’s over the last 12 months.

PXXLF's P/E Growth Rating (1) in the null industry is significantly better than the same rating for CRMD (99) in the Medical Specialties industry. This means that PXXLF’s stock grew significantly faster than CRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRMDPXXLF
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
6%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
6%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRSNX12.940.08
+0.62%
JH Adaptive Risk Mgd U.S. Eq N
FSENX59.28N/A
N/A
Fidelity Select Energy Portfolio
GGGCX52.48N/A
N/A
Gabelli Global Growth C
MIDLX34.58N/A
N/A
MFS International New Discovery R6
NUGIX37.31N/A
N/A
Nuveen Global Dividend Growth I

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
+0.99%
MURA - CRMD
38%
Loosely correlated
N/A
ARTL - CRMD
33%
Poorly correlated
+4.49%
RLYB - CRMD
32%
Poorly correlated
-3.39%
XLO - CRMD
31%
Poorly correlated
-1.95%
AXON - CRMD
30%
Poorly correlated
+2.84%
More

PXXLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXXLF has been loosely correlated with RLYB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PXXLF jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXXLF
1D Price
Change %
PXXLF100%
N/A
RLYB - PXXLF
44%
Loosely correlated
-3.39%
VERU - PXXLF
37%
Loosely correlated
-1.44%
SEOVF - PXXLF
28%
Poorly correlated
N/A
BRTX - PXXLF
25%
Poorly correlated
+0.32%
CRMD - PXXLF
24%
Poorly correlated
+0.99%
More